Skip to main content

Pharmaceutical Quality Control

September 25, 2024

The Vital Role of Prevention and Early Detection as Dengue Cases Rise

With cases increasing at an alarming rate over the past two decades, the dengue virus (DENV) has remained a significant threat to global public health. The World Health Organization (WHO) reports that dengue cases skyrocketed from 500,000 to 5.2 million from 2000-2019, and recent reports indicate that cases are on the rise again. As of early 2024, dengue has been classified as a Grade 3 emergency by the WHO, demanding the highest-level response. Although many dengue cases are mild, severe dengue is considered a medical emergency that necessitates intervention as soon as possible. As dengue cases continue to increase, an integrated approach that includes vector control, prevention, and early and accurate diagnosis is critical for mitigation.
  • October 11, 2023

    Unlocking the potential of pharmaceutical production whilst elevating patient safety

    Scientific discoveries, however important, are not enough to improve public health. Manufacturing infrastructure and innovation are needed to allow pharmaceutical companies to successfully and safely produce products at scale and make them available to clinicians and their patients.
  • July 01, 2022

    The Four Key Benefits of RMM

    Over the past few years, industry leaders are increasingly investing in rapid microbiological methods (RMMs) and have already realized significant gains in detection sensitivity, automation, throughput, and time-to-result.
  • March 10, 2022

    How Quality Control Testing Helps Ensure Vaccine Safety

    How Quality Control Testing Helps Ensure Vaccine Safety?
  • March 09, 2022

    What Horseshoe Crabs Have to Do with Vaccine Development—and Why It’s a Problem

    What Horseshoe Crabs Have to Do with Vaccine Development—and Why It’s a Problem?